Literature DB >> 28088340

The role of magnetic resonance imaging techniques in evaluation and management of the idiopathic inflammatory myopathies.

Jessica Day1, Sandy Patel2, Vidya Limaye3.   

Abstract

Magnetic resonance imaging (MRI) is an important tool in the evaluation of neuromuscular disorders. MRI accurately demonstrates muscle oedema, atrophy, subcutaneous pathology and fatty infiltration and also highlights the distribution of muscle involvement. This review examines the role of MRI in evaluation of the idiopathic inflammatory myopathies (IIMs), a heterogeneous group of autoimmune conditions characterised by muscle inflammation and a variety of extra-muscular manifestations. MRI has a clear role in aiding diagnosis of these conditions, guiding muscle biopsy, differentiating subtypes of IIM using a pattern-based approach, and monitoring disease activity in a longitudinal fashion. Whole body MRI is an emerging technique that offers several advantages over regional MRI, but is not currently widely available. We will also consider newer MRI techniques which provide detailed information regarding the metabolism, function and structure of muscle, although their use is restricted to research purposes at present.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  idiopathic inflammatory myopathy; magnetic resonance imaging; myositis

Mesh:

Year:  2016        PMID: 28088340     DOI: 10.1016/j.semarthrit.2016.11.001

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  14 in total

Review 1.  Update on outcome assessment in myositis.

Authors:  Lisa G Rider; Rohit Aggarwal; Pedro M Machado; Jean-Yves Hogrel; Ann M Reed; Lisa Christopher-Stine; Nicolino Ruperto
Journal:  Nat Rev Rheumatol       Date:  2018-04-12       Impact factor: 20.543

Review 2.  Diagnostic Imaging of Inflammatory Myopathies: New Concepts and a Radiological Approach.

Authors:  Júlio Brandão Guimarães; Marcelo A Nico; Alípio G Omond; Laís Uyeda Aivazoglou; Rafael Baches Jorge; Edmar Zanoteli; Artur R C Fernandes
Journal:  Curr Rheumatol Rep       Date:  2019-02-14       Impact factor: 4.592

3.  Sporadic late-onset nemaline myopathy: clinical, pathology and imaging findings in a single center cohort.

Authors:  Mauro Monforte; Guido Primiano; Gabriella Silvestri; Massimiliano Mirabella; Marco Luigetti; Cristina Cuccagna; Enzo Ricci; Serenella Servidei; Giorgio Tasca
Journal:  J Neurol       Date:  2018-01-22       Impact factor: 4.849

Review 4.  Clinical Characteristics of Myositis Associated with Graft-Versus-Host Disease.

Authors:  Sandhya Limaye; Vidya Limaye
Journal:  Curr Rheumatol Rep       Date:  2021-04-24       Impact factor: 4.592

5.  Clinical value of a [18F]-FDG PET-CT muscle-to-muscle SUV ratio for the diagnosis of active dermatomyositis.

Authors:  Nihal Martis; Philippe Viau; Thierry Zenone; Fanny Andry; Aurélie Grados; Mikael Ebbo; Emeline Castela; Benoit Brihaye; Eric Denis; Stéphane Liguori; Alexandra Audemard; Yoland Schoindre; Anne-Sophie Morin; Benjamin Terrier; Laurent Marcq; Nicolas Mounier; Olivier Lidove; Jean-Philippe Chaborel; Denis Quinsat
Journal:  Eur Radiol       Date:  2019-06-27       Impact factor: 5.315

Review 6.  Idiopathic Inflammatory Myopathies: A Review of the Classification and Impact of Pathogenesis.

Authors:  Dana E Mandel; Charles J Malemud; Ali D Askari
Journal:  Int J Mol Sci       Date:  2017-05-18       Impact factor: 5.923

7.  Factors associated with refractory autoimmune necrotizing myopathy with anti-signal recognition particle antibodies.

Authors:  Yawen Zhao; Wei Zhang; Yilin Liu; Zhaoxia Wang; Yun Yuan
Journal:  Orphanet J Rare Dis       Date:  2020-07-08       Impact factor: 4.123

8.  MRI of skeletal muscles in patients with idiopathic inflammatory myopathies: characteristic findings and diagnostic performance in dermatomyositis.

Authors:  Taro Ukichi; Ken Yoshida; Satoshi Matsushima; Go Kawakami; Kentaro Noda; Kazuhiro Furuya; Daitaro Kurosaka
Journal:  RMD Open       Date:  2019-03-28

Review 9.  New Myositis Classification Criteria-What We Have Learned Since Bohan and Peter.

Authors:  Valérie Leclair; Ingrid E Lundberg
Journal:  Curr Rheumatol Rep       Date:  2018-03-17       Impact factor: 4.592

Review 10.  Current Classification and Management of Inflammatory Myopathies.

Authors:  Jens Schmidt
Journal:  J Neuromuscul Dis       Date:  2018
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.